GIC
BSX icon

Gantzert Investment Company’s Boston Scientific BSX Stock Holding History

Gantzert Investment Company’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-500
Closed -$16K – 55
2020
Q1 		$16K Hold
500
– – 0.02% 53
2019
Q4 		$23K Hold
500
– – 0.02% 52
2019
Q3 		$20K Hold
500
– – 0.02% 53
2019
Q2 		$21K Hold
500
– – 0.02% 59
2019
Q1 		$19K Hold
500
– – 0.02% 58
2018
Q4 		$18K Buy
+500
New +$18.1K 0.02% 58

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gantzert Investment Company's BSX Position: Q2 2020 in Review

Gantzert Investment Company sold out of Boston Scientific (BSX) in Q2 2020, closing a stake of 500 shares — an estimated $16K sold.

Gantzert Investment Company first reported a position in BSX in Q4 2018 and held it in 6 quarters. The position peaked at $23K in Q4 2019. 841 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

  • Gantzert Investment Company reported no remaining Boston Scientific position as of Q2 2020 after selling out during the quarter.
  • Gantzert Investment Company sold 500 Boston Scientific shares in Q2 2020, an estimated $16K.
  • Gantzert Investment Company first reported a position in Boston Scientific in Q4 2018 and held it in 6 quarters.
  • Gantzert Investment Company's Boston Scientific position peaked at $23K in Q4 2019.
  • 841 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on Gantzert Investment Company's 13F filing for Q2 2020, filed 1 Jul 2020.